Titre : Traitements médicamenteux de la COVID-19

Traitements médicamenteux de la COVID-19 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Traitements médicamenteux de la COVID-19 : Questions médicales les plus fréquentes", "headline": "Traitements médicamenteux de la COVID-19 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Traitements médicamenteux de la COVID-19 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-17", "dateModified": "2025-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Traitements médicamenteux de la COVID-19" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Traitement médicamenteux", "url": "https://questionsmedicales.fr/mesh/D004358", "about": { "@type": "MedicalCondition", "name": "Traitement médicamenteux", "code": { "@type": "MedicalCode", "code": "D004358", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.319" } } }, "about": { "@type": "MedicalCondition", "name": "Traitements médicamenteux de la COVID-19", "alternateName": "COVID-19 Drug Treatment", "code": { "@type": "MedicalCode", "code": "D000093485", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Didier Raoult", "url": "https://questionsmedicales.fr/author/Didier%20Raoult", "affiliation": { "@type": "Organization", "name": "Aix-Marseille Université, IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, 19-21 boulevard Jean Moulin, 13385 Marseille Cedex 05, France; IHU-Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385 Marseille Cedex 05, France." } }, { "@type": "Person", "name": "Francesco Potì", "url": "https://questionsmedicales.fr/author/Francesco%20Pot%C3%AC", "affiliation": { "@type": "Organization", "name": "Department of Medicine and Surgery - Unit of Neurosciences, University of Parma, Parma, Italy. francesco.poti@unipr.it." } }, { "@type": "Person", "name": "Taher Entezari-Maleki", "url": "https://questionsmedicales.fr/author/Taher%20Entezari-Maleki", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. tentezari@gmail.com." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "David Brandariz-Nuñez", "url": "https://questionsmedicales.fr/author/David%20Brandariz-Nu%C3%B1ez", "affiliation": { "@type": "Organization", "name": "Servicio de Farmacia, Hospital Quironsalud, Barcelona, España. Electronic address: vrandariz@gmail.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Enhanced sensing performance of tapered profile in the apodized fiber Bragg grating for detection of cancerous cells utilizing their refractive index.", "datePublished": "2023-09-05", "url": "https://questionsmedicales.fr/article/37669917", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jbio.202300237" } }, { "@type": "ScholarlyArticle", "name": "A Framework for Detecting Thyroid Cancer from Ultrasound and Histopathological Images Using Deep Learning, Meta-Heuristics, and MCDM Algorithms.", "datePublished": "2023-08-27", "url": "https://questionsmedicales.fr/article/37754937", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/jimaging9090173" } }, { "@type": "ScholarlyArticle", "name": "Asymmetrically split DNAzyme-based colorimetric and electrochemical dual-modal biosensor for detection of breast cancer exosomal surface proteins.", "datePublished": "2023-07-26", "url": "https://questionsmedicales.fr/article/37542978", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bios.2023.115552" } }, { "@type": "ScholarlyArticle", "name": "Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37099047", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13550-023-00984-5" } }, { "@type": "ScholarlyArticle", "name": "The Resection Rate of Synchronously Detected Liver and Lung Metastasis from Colorectal Cancer Is Low-A National Registry-Based Study.", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36900225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers15051434" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Traitement médicamenteux", "item": "https://questionsmedicales.fr/mesh/D004358" }, { "@type": "ListItem", "position": 4, "name": "Traitements médicamenteux de la COVID-19", "item": "https://questionsmedicales.fr/mesh/D000093485" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Traitements médicamenteux de la COVID-19 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Traitements médicamenteux de la COVID-19", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Traitements médicamenteux de la COVID-19", "description": "Les vaccins préviennent-ils la COVID-19 ?\nQuelles mesures de prévention sont recommandées ?\nLes traitements préventifs existent-ils ?\nLes masques chirurgicaux sont-ils efficaces ?\nLa vaccination est-elle obligatoire ?", "url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Traitements médicamenteux de la COVID-19", "description": "Quels médicaments sont utilisés pour traiter la COVID-19 ?\nComment fonctionne le remdesivir ?\nLa dexaméthasone est-elle efficace pour tous les patients ?\nQuels sont les effets secondaires des traitements ?\nLes antibiotiques sont-ils utiles contre la COVID-19 ?", "url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Traitements médicamenteux de la COVID-19", "description": "Quelles sont les complications possibles de la COVID-19 ?\nComment la COVID-19 affecte-t-elle le cœur ?\nLes séquelles de la COVID-19 sont-elles fréquentes ?\nLa COVID-19 peut-elle affecter le système nerveux ?\nQuels sont les risques de thrombose ?", "url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Traitements médicamenteux de la COVID-19", "description": "Quels sont les principaux facteurs de risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLe sexe influence-t-il la gravité de la maladie ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'origine ethnique influence-t-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Les vaccins préviennent-ils la COVID-19 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins réduisent le risque d'infection et de formes graves de la maladie." } }, { "@type": "Question", "name": "Quelles mesures de prévention sont recommandées ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le port du masque, la distanciation sociale et le lavage des mains sont essentiels." } }, { "@type": "Question", "name": "Les traitements préventifs existent-ils ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme les anticorps monoclonaux peuvent être utilisés en prévention chez certains patients." } }, { "@type": "Question", "name": "Les masques chirurgicaux sont-ils efficaces ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils réduisent la transmission du virus en filtrant les gouttelettes respiratoires." } }, { "@type": "Question", "name": "La vaccination est-elle obligatoire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend des réglementations locales, mais elle est fortement recommandée." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour traiter la COVID-19 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des antiviraux comme le remdesivir et des corticostéroïdes comme la dexaméthasone sont utilisés." } }, { "@type": "Question", "name": "Comment fonctionne le remdesivir ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le remdesivir inhibe la réplication du virus en bloquant l'ARN polymérase virale." } }, { "@type": "Question", "name": "La dexaméthasone est-elle efficace pour tous les patients ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle est efficace principalement chez les patients gravement malades nécessitant de l'oxygène." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des infections, des troubles gastro-intestinaux et des réactions allergiques." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils utiles contre la COVID-19 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne traitent pas les infections virales comme la COVID-19." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la COVID-19 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la pneumonie, le syndrome de détresse respiratoire et des problèmes cardiaques." } }, { "@type": "Question", "name": "Comment la COVID-19 affecte-t-elle le cœur ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des myocardites et des arythmies, augmentant le risque de complications cardiaques." } }, { "@type": "Question", "name": "Les séquelles de la COVID-19 sont-elles fréquentes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux patients présentent des symptômes persistants, appelés COVID long." } }, { "@type": "Question", "name": "La COVID-19 peut-elle affecter le système nerveux ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes neurologiques comme des maux de tête et des troubles de l'odorat peuvent survenir." } }, { "@type": "Question", "name": "Quels sont les risques de thrombose ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La COVID-19 augmente le risque de thrombose veineuse et d'embolie pulmonaire." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, les maladies chroniques et l'obésité." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus à risque ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles présentent un risque accru de formes graves de la COVID-19." } }, { "@type": "Question", "name": "Le sexe influence-t-il la gravité de la maladie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent que les hommes peuvent avoir des formes plus graves que les femmes." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires ou cardiovasculaires augmentent le risque." } }, { "@type": "Question", "name": "L'origine ethnique influence-t-elle le risque ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que certaines ethnies peuvent être plus touchées par la COVID-19." } } ] } ] }

Sources (10000 au total)

Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy.

Prostate-Specific Membrane Antigen (PSMA) PET/CT and multiparametric MRI (mpMRI) are well-established modalities for identifying intra-prostatic lesions (IPLs) in localised prostate cancer. This study... PSMA PET/CT and mpMRI data from 19 prostate cancer patients were co-registered with whole-mount histopathology using an established registration framework. Apparent Diffusion Coefficient (ADC) maps we... Perfusion parameters from DCE MRI were more highly correlated with PET SUV than ADC or T2w. IPLs were best detected with a Random Forest Classifier using radiomic features from PET and mpMRI rather th... Machine learning classifiers using radiomic features from PSMA PET and mpMRI show promise for predicting IPLs and differentiating between high-grade and low-grade disease, which could be used to infor...

Risk and prognostic factors of invasive gastric cancer detection during surveillance endoscopy: Multi-institutional cross-sectional study.

Esophagogastroduodenoscopy (EGD) is important for the detection of curable gastric cancer (GC). However, there are no appropriate surveillance data during routine endoscopic inspections. This study ai... This was a retrospective, multicenter, cross-sectional study conducted in 15 Japanese hospitals. We retrospectively analyzed patients with GC who had previously undergone surveillance endoscopy at eac... In total, 1085 patients with GCs detected during surveillance endoscopy were enrolled. The multivariate logistic analysis revealed that current Hp infection (odds ratio [OR] 2.18; 95% confidence inter... In this study, a surveillance interval of >1.5 years and current Hp infection were independent risk factors for detecting pT1b or deeper GC. Additionally, these factors were poor prognostic factors of...

Massively parallel sequencing of endometrial lavage specimens for the detection of cancer-associated mutations in atypical and non-atypical endometrial hyperplasia.

Endometrial hyperplasia (EH), particularly with atypia, is considered an antecedent of endometrial adenocarcinoma. In this study, we aimed to apply massively parallel sequencing of endometrial lavage ... Endometrial lavage specimens and parallel biopsy samples (... On analyzing sequencing data, the presence of at least one cancer-associated gene mutation was identified in 72.7 and 44.4% of endometrial lavage specimens obtained from women with AEH and NEH, respec... Endometrial hyperplasia is characterized by a high burden of cancer-associated mutations, particularly in the presence of atypia. Our study, albeit performed with a relatively small number of samples,...